🚀 Meet Asgard Therapeutics at CICON 2024 & ESMO Congress 2024! Pereira Lab will be presenting at CICON 2024 on Sept 9th, 5:15 PM. 🤝 Fábio Rosa will also attend. Meet with Xiaoli Huang, Project Director in Preclinical Pharmacology, at the ESMO Congress 2024 Let's connect!

✨We’re thrilled to announce that Asgard Therapeutics is a finalist for the 2024 European Lifestars Awards! 🎉 Nominated for Biotech Company of the Year and Women-Led Business Leader of the Year with our CEO, Cristiana Pires! Looking forward to the awards on November 18 in London!

🚀 Meet Asgard Therapeutics at two major events this October! Scientist Fritiof Åkerström will present at ESGCT 2024 on October 23rd, 8:30-10:00 AM in Rome! Also, connect with Xavier Catena at the AACR poster session on October 19th, 6:00-8:15 PM in Boston. #ESGCT2024 #AACR2024

🌍 Join Asgard Therapeutics at #BIOEUROPE2024 in Stockholm, Nov 4-6! 🗣️ Fireside Chat with CEO Cristiana Pires Topic: "All for You": Transforming patient care with Intratumoral Therapy 📅 Nov 5 | 🕒 12:30-13:00 | 📍 Exhibit Hall Stage Meet the Asgard team!

Join Asgard Therapeutics at #ESMOIO2024 in Geneva! 🎤 Our Co-founder & CEO, Cristiana Pires speaks on Dec 13, 10:30–10:45, Room C. #AsgardTherapeutics #ImmunoOncology #ESMOIO2024

🚀 €2.5m secured! Asgard Therapeutics, Lund University & HerlevGentofte Hosp. have secured EIC Transition funding to advance TIL-based immunotherapy. 🔬Repro-TIL tackles challenges in TIL therapy using Asgard’s dendritic cell reprogramming to expand activated, (neo)antigen-reactive T cells.

📢 Exciting news! We’ve appointed experienced immunology drug development specialist Shane Olwill as Chief Development Officer! Shane will lead IND-enabling studies & clinical trials planning for our lead asset AT-108. See here for more bit.ly/4iQLtD1

🚨 We’re Hiring! Asgard Therapeutics is hiring a CMC Program Lead. Work with internal teams, vendors, and consultants, manage risks, and support regulatory submissions. 🌍 Remote with occasional travel. Apply here: lnkd.in/dte_V87T #AsgardTherapeutics #CMC #Hiring

🚨 We’re Hiring! Asgard Therapeutics is hiring a CMC Program Lead. Work with internal teams, vendors, and consultants, manage risks, and support regulatory submissions. 📷 Remote with occasional travel. Apply here: lnkd.in/dte_V87T #AsgardTherapeutics #CMC #Hiring

🚨 We’re hiring a Scientist – In vivo Immuno-Oncology! Run mouse studies, test AT-108 + small molecules, perform immunoassays & analyze data. 🔗 Apply here: lnkd.in/dpeUNxkN 👉 Also hiring: CMC Lead lnkd.in/dte_V87T #Hiring #BiotechJobs #CancerImmunotherapy

#Asgard is joining the Lund Spring Symposium next week, an event filled with presentations from world-class experts and industry leaders. Our CEO Cristiana Pires is presenting on developing in vivo direct reprogramming of tumor cells as a new form of cancer immunotherapy.

🌟Asgard Therapeutics welcomes leading experts in drug development and cancer immunotherapy to the company. Dr Cristina Csimma joins our Board of Directors, while Prof Ignacio Melero and Prof Brian Brown join our Clinical and Scientific Advisory Board. Read more: bit.ly/4dH0wxc

#Asgard's scientific co-founders are presenting at major industry conferences this June! Details👇 ISSCR 2025: 📅 11 June 🕣 08:30 AM - 10:00 AM HKT 📣 Presenter: Pereira Lab Frontiers in Cancer Immunotherapy 2025: 📅 16 June 🕞 3:35 PM - 4:05 PM EST 📣 Presenter: Fabio Rosa

Join us on June 23rd at Medicon Village for Lund Immunotalks – a morning on #immunoOncology! 🎙️ Aurelien Marabelle, Gustave Roussy, Paris 🎙️ Brian Brown, Mount Sinai, New York Fika by Miltenyi Biotec 🕘 09:00–11:00 📍 Restaurant Inspira, Medicon Village

Last week, #AsgardTherapeutics held its 4th annual Advisory Board meeting, bringing together key voices for an insightful gathering to discuss our lead candidate AT-108, and officially welcome Prof Brian Brown and Prof Ignacio Melero 💭 Discover more at asgardthx.com